Investor Alert

Cerecor Inc.



After Hours

 --Quotes are delayed by 20 min

Dec 6, 2019, 4:00 p.m.





0.00 0.00%


Volume 1,076

Quotes are delayed by 20 min


Previous close

$ 3.37

$ 4.00


+0.63 +18.69%

Day low

Day high




52 week low

52 week high




Simon C. Pedder

Founder of Chelsea Therapeutics International Ltd., Simon C. Pedder is a businessperson who has been at the helm of 6 different companies is Chief Business & Strategy Officer at Athenex, Inc. and on the board of 5 other companies.

In the past he was President, Chief Executive Officer & Director at Cellectar BioSciences, Inc. and Chief Executive Officer & Director at Novelos Therapeutics, Inc. (a subsidiary of Cellectar BioSciences, Inc.), President & Chief Executive Officer at Chelsea Therapeutics, Inc., President & Chief Executive Officer at Chelsea Therapeutics International Ltd., President & Chief Executive Officer at Ivory Capital Corp., Vice President-Pharmaceutical Business & Oncology at Hoffmann-La Roche, Inc. and Vice President-Drug Development at Shearwater Corp.

Simon C. Pedder received an undergraduate degree from The University of Waterloo, a graduate degree from Concordia University and a doctorate from the University of Saskatchewan College of Medicine.


Date Shares Transaction Value
08/27/2019 6,734   Acquisition at $2.98 per share. 20,067
05/24/2019 250,000   Award at $0 per share. 0
05/14/2019 6,000   Acquisition at $5.06 per share. 30,360

Officers and Executives

Dr. Simon C. Pedder
Executive Chairman
Mr. Joseph M. Miller
Secretary, Chief Financial & Accounting Officer
Dr. Perry Calias
Chief Scientific Officer
Dr. Bernadine Heather Fraser
VP-Clinical Operations & Project Management
Mr. Peter S. Greenleaf
Dr. Uli Alf Hacksell
Mr. Steven Joseph Boyd
Mr. James A. Harrell
Chief Commercial Officer
Mr. Keith W. Schmidt
Independent Director
Mr. Phil Gutry
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Link to MarketWatch's Slice.